2023年6月最新SCI影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。 ![]() |
基本信息 | 登录收藏 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | ACS Infectious Diseases ACS Infect. Dis. (此期刊被最新的JCR期刊SCIE收录) LetPub评分 7.6
53人评分
我要评分
声誉 8.7 影响力 6.3 速度 9.3 | |||||||||||||||||
期刊ISSN | 2373-8227 | 微信扫码收藏此期刊 | ||||||||||||||||
2022-2023最新影响因子 (数据来源于搜索引擎) | 5.3 点击查看影响因子趋势图 | |||||||||||||||||
实时影响因子 | 截止2023年9月27日:2.447 | |||||||||||||||||
2022-2023自引率 | 3.80%点击查看自引率趋势图 | |||||||||||||||||
五年影响因子 | 5.1 | |||||||||||||||||
h-index | 22 | |||||||||||||||||
CiteScore |
| |||||||||||||||||
期刊简介 | ACS Infectious Diseases是第一本以强调化学及其在传染病研究等多学科领域协作的期刊。该期刊涵盖了与传染病研究有关的化学研究的所有方面,包括病原体、宿主-病原体相互作用、治疗、诊断、疫苗、药物递送系统以及其他与传染病有关的生物医学技术开发的研究。该期刊的编辑精通传染病的化学和生物学领域,旨在为这两个学科之间的建立桥梁。 ACS Infectious Diseases欢迎平衡了化学与生物领域的相关稿件,并鼓励围绕特定病原体和疾病展开相关问题的讨论。 ACS Infectious Diseases is the first journal to highlight chemistry and its role in the multidisciplinary and collaborative field of infectious disease research. The scope of the journal encompasses all aspects of chemistry relating to infectious diseases research including research on pathogens, host-pathogen interactions, therapeutics, diagnostics, vaccines, drug-delivery systems, and other biomedical technology development pertaining to infectious diseases. With editors well-versed in both chemistry and the biology of infectious diseases, the journal aims to bridge the gap between these two disciplines. ACS Infectious Diseases welcomes submission of articles with a balance of chemistry and biology, and encourages discussions centered on specific pathogen- and disease-related issues. | |||||||||||||||||
期刊官方网站 | https://pubs.acs.org/journal/aidcbc | |||||||||||||||||
期刊投稿网址 | https://acs.manuscriptcentral.com/acs | |||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足ACS Infectious Diseases的语言要求,还能让ACS Infectious Diseases编辑和审稿人得到更好的审稿体验,让稿件最大限度地被ACS Infectious Diseases编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||
是否OA开放访问 | Transformative (TJ转换期刊是订阅式/混合期刊,但是正在积极转为完全开放获取期刊。查看ACS说明。) | |||||||||||||||||
通讯方式 | AMER CHEMICAL SOC, 1155 16TH ST, NW, WASHINGTON, USA, DC, 20036 | |||||||||||||||||
出版商 | American Chemical Society | |||||||||||||||||
涉及的研究方向 | CHEMISTRY, MEDICINALINFECTIOUS DISEASES&nb-INFECTIOUS DISEASES | |||||||||||||||||
出版国家或地区 | UNITED STATES | |||||||||||||||||
出版语言 | English | |||||||||||||||||
出版周期 | Monthly | |||||||||||||||||
出版年份 | 2015 | |||||||||||||||||
年文章数 | 221点击查看年文章数趋势图 | |||||||||||||||||
Gold OA文章占比 | 13.30% | |||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 95.48% | |||||||||||||||||
WOS期刊SCI分区 ( 2022-2023年最新版) | WOS分区等级:1区
| |||||||||||||||||
中科院《国际期刊预警 名单(试行)》名单 | 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2021年01月发布的2020版:不在预警名单中 | |||||||||||||||||
中科院SCI期刊分区 ( 2022年12月最新升级版) | 点击查看中科院SCI期刊分区趋势图
| |||||||||||||||||
中科院SCI期刊分区 ( 2021年12月基础版) |
| |||||||||||||||||
中科院SCI期刊分区 ( 2021年12月升级版) |
| |||||||||||||||||
中科院SCI期刊分区 ( 2020年12月旧的升级版) |
| |||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) | |||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2373-8227%5BISSN%5D | |||||||||||||||||
平均审稿速度 | 网友分享经验: | |||||||||||||||||
平均录用比例 | 网友分享经验: | |||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在ACS Infectious Diseases顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||||||||
收稿范围 | 期刊官网数据: 期刊收录研究方向: 病原体、宿主-病原体相互作用:利用结构生物学、化学生物学、糖生物学、物理化学、核酸化学和生物化学阐释发病机理的分子机制,剖析发病机理的工具的开发 疗法:基于靶标、表型或计算的方法,发现和开发治疗传染病的新药剂,重点在于建立作用机制,了解结合模式和抑制机制,和/或讨论病原体特异性给药物开发带来的挑战;开发新技术以促进表征、验证和确定潜在药物靶标的优先次序或评估抗感染剂细胞渗透的理化基础;药物抗性的机理研究 疫苗:合成疫苗和小分子疫苗佐剂的发现和开发;表位结合的结构、物理或计算研究 诊断:利用物理、表面、分析和纳米化学技术开发新型且改进的诊断方法;利用结构生物学、分子生物学和化学生物学研究诊断目标 药物输送系统:使用新型材料和技术,例如纳米技术,来递送抗生素 | |||||||||||||||||
收录体裁 | 期刊官网数据: Articles Featured Articles Letters Reviews Perspectives Viewpoints | |||||||||||||||||
期刊常用信息链接 |
|
|
|
|
中国学者近期发表的论文 | |
1. | Formulation and Evaluation of Lipidized Imiquimod as an Effective Adjuvant Author: Yin, Wenzhu; Deng, Bihua; Xu, Zeyu; Wang, Haiyan; Ma, Fang; Zhou, Mingxu; Lu, Yu; Zhang, Jinqiu Journal: ACS INFECTIOUS DISEASES. 2023; Vol. 9, Issue 2, pp. 378-387. DOI: 10.1021/acsinfecdis.2c00583 PubMed DOI |
2. | Identification and Molecular Modification of Staphylococcus aureus Bacteriophage Lysin LysDZ25 Author: Chang, Yan; Li, Qingbin; Zhang, Shuhang; Zhang, Qing; Qi, Qingsheng; Lu, Xuemei; Liu, Yuqing Journal: ACS INFECTIOUS DISEASES. 2023; Vol. , Issue , pp. -. DOI: 10.1021/acsinfecdis.2c00493 PubMed DOI |
3. | Pseudolaric Acid B Ameliorates Fungal Keratitis Progression by Suppressing Inflammation and Reducing Fungal Load Author: Yin, Min; Li, Na; Zhang, Lina; Lin, Jing; Wang, Qian; Gu, Lingwen; Zheng, Hengrui; Zhao, Guiqiu; Li, Cui Journal: ACS INFECTIOUS DISEASES. 2023; Vol. , Issue , pp. -. DOI: 10.1021/acsinfecdis.2c00536 PubMed DOI |
4. | Long-Term Immunogenicity and In Vitro Prophylactic Protective Efficacy of M. tuberculosis Fusion Protein DR2 Combined with Liposomal Adjuvant DIMQ as a Boosting Vaccine for BCG Author: Wang, Xiao-chun; Xu, Li-fa; Zhang, Yan-peng; Mao, Li-rong; Du, Jian-peng; Sun, Qi-shan; Shi, Zi-lun; Xing, Ying-ru; Su, Yi-xin; Wang, Sheng-jian; Wang, Jian; Ma, Ji-lei; Zhang, Jing-yan Journal: ACS INFECTIOUS DISEASES. 2023; Vol. , Issue , pp. -. DOI: 10.1021/acsinfecdis.2c00570 PubMed DOI |
5. | Antimicrobial Zeolitic Imidazolate Frameworks with Dual Mechanisms of Action Author: Yan, Yunxiang; Li, Ye; Li, Hong; Ma, Xiang; Tang, Yanqiong; Yi, Kexian; Lin, Xiangmin; Li, Juanjuan; Liu, Zhu Journal: ACS INFECTIOUS DISEASES. 2023; Vol. , Issue , pp. -. DOI: 10.1021/acsinfecdis.2c00496 PubMed DOI |
6. | Temporin-GHb-Derived Peptides Exhibit Potent Antibacterial and Antibiofilm Activities against Staphylococcus aureus In Vitro and Protect Mice from Acute Infectious Pneumonia Author: Jin, Xiao; Hu, Xuanyu; Jiang, Shangjun; Zhao, Ting; Zha, Yanmei; Wei, Shuangshuang; Zhao, Jianguo; Wang, Manchuriga; Zhang, Yingxia Journal: ACS INFECTIOUS DISEASES. 2023; Vol. 9, Issue 4, pp. 840-855. DOI: 10.1021/acsinfecdis.2c00544 PubMed DOI |
7. | Alanyl-Glutamine (Ala-Gln) Ameliorates Dextran Sulfate Sodium (DSS)-Induced Acute Colitis by Regulating the Gut Microbiota, PI3K-Akt/NF-?B/STAT3 Signaling, and Associated Pulmonary Injury Author: Liu, Jing; Zong, Chengguo; Yu, Xin; Ding, Yan; Chang, Bing; Wang, Ruoyu; Sang, Lixuan Journal: ACS INFECTIOUS DISEASES. 2023; Vol. , Issue , pp. 979-992. DOI: 10.1021/acsinfecdis.3c00014979 PubMed DOI |
8. | Alanyl-Glutamine (Ala-Gln) Ameliorates Dextran Sulfate Sodium (DSS)-Induced Acute Colitis by Regulating the Gut Microbiota, PI3K-Akt/NF-?B/STAT3 Signaling, and Associated Pulmonary Injury Author: Liu, Jing; Zong, Chengguo; Yu, Xin; Ding, Yan; Chang, Bing; Wang, Ruoyu; Sang, Lixuan Journal: ACS INFECTIOUS DISEASES. 2023; Vol. 9, Issue 4, pp. 979-992. DOI: 10.1021/acsinfecdis.3c00014 PubMed DOI |
9. | Human Polo-like Kinase Inhibitors as Antiplasmodials Author: Bohmer, Monica J.; Wang, Jinhua; Istvan, Eva S.; Luth, Madeline R.; Collins, Jennifer E.; Huttlin, Edward L.; Wang, Lushun; Mittal, Nimisha; Hao, Mingfeng; Kwiatkowski, Nicholas P.; Gygi, Steven P.; Chakrabarti, Ratna; Deng, Xianming; Goldberg, Daniel E.; Winzeler, Elizabeth A.; Gray, Nathanael S.; Chakrabarti, Debopam Journal: ACS INFECTIOUS DISEASES. 2023; Vol. 9, Issue 4, pp. 1004-1021. DOI: 10.1021/acsinfecdis.3c00025 PubMed DOI |
10. | Ultrafast, One-Step, Label-Based Biosensor Diagnosis Platform for the Detection of Mycobacterium tuberculosis in Clinical Applications Author: Yang, Xinggui; Chen, Xu; Huang, Junfei; Chen, Yijiang; Zheng, Wenlin; Chen, Wei; Chen, Huijuan; Lei, Shiguang; Li, Shijun Journal: ACS INFECTIOUS DISEASES. 2023; Vol. 9, Issue 4, pp. 762-772. DOI: 10.1021/acsinfecdis.2c00475 PubMed DOI |
|
|
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分: | |
同领域作者分享投稿经验:共3条 (包含回复) |
我来分享 |
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2023 中国: LetPub上海分公司 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960
增值电信业务经营许可证:沪B2-20211595
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦2103室
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451